Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03865472 · ClinicalTrials.gov registry record · NA
rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers
A NA study of Cigarette Smoker and Current Smoker, sponsored by Roswell Park Cancer Institute.
- Active
- Registry status
- NA
- Development phase
- 206
- Enrollment target
- 1
- Study location
NCT03865472 is a NA study of Cigarette Smoker and Current Smoker that is active but no longer recruiting, run by Roswell Park Cancer Institute. The registered enrollment target is 206 participants, below the 875-participant average among 5 other Cigarette Smoker trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03865472, a NA study of Cigarette Smoker and Current Smoker, is active but no longer recruiting, sponsored by Roswell Park Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies best dose and how well repetitive transcranial magnetic stimulation (rTMS) works in promoting smoking cessation and preventing relapse in current smokers. rTMS is a form of brain stimulation therapy that controls nerve cell activity, increases blood flow in the brain, and improves cognitive function.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Sham Intervention
- PROCEDURE Repetitive Transcranial Magnetic Stimulation
Study Locations (1)
New York
- Roswell Park Cancer Institute - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2018-11-10 |
| Est. Completion | 2026-11-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03865472
The ClinicalTrials.gov registry entry for NCT03865472 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 875-participant average among 5 other Cigarette Smoker trials with a reported enrollment target (76% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cigarette Smoker appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT03865472 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03865472 about?
NCT03865472 is a clinical study titled "rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers". This trial studies best dose and how well repetitive transcranial magnetic stimulation (rTMS) works in promoting smoking cessation and preventing relapse in current smokers. rTMS is a form of brain stimulation therapy that controls nerve cell activity, increases blood flow in the brain, and improves...
What is the current status of trial NCT03865472?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 206 participants. The study started on 2018-11-10. Estimated completion is 2026-11-13.
What conditions does trial NCT03865472 study?
This clinical trial studies the following conditions: Cigarette Smoker, Current Smoker, Current Every Day Smoker.
What interventions are being tested in trial NCT03865472?
The interventions under investigation include: Questionnaire Administration (OTHER), Sham Intervention (PROCEDURE), Repetitive Transcranial Magnetic Stimulation (PROCEDURE).
Who is sponsoring clinical trial NCT03865472?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03865472 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoker
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
RECRUITING · NA
-
Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
ACTIVE NOT RECRUITING · NA
-
Validation of Biomarkers of Exposure and Host Response
COMPLETED · NA
-
Varenicline and Combined NRT for Smoking Cessation
ACTIVE NOT RECRUITING · Phase 4
-
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.